Markets |
Wall St. declines on China fears, weak profit expectations
DJ: 17,081.89 -49.97 NAS: 4,796.61
-42.03 S&P: 2,003.69
-13.77
REUTERS/BRENDAN
MCDERMID
U.S. stocks fell on Tuesday, with the Dow snapping a
seven-day winning streak, on renewed fears of slowing growth in China and another bout of
selling in biotech shares.
Biotechs led the S&P
500 and Nasdaq lower and the S&P health care
index .SPXHC, down 1.2 percent, had the biggest losses among S&P sectors,
followed by industrials .SPLRCI, down 1.1 percent. The Nasdaq Biotech Index .NBI was down 3.2
percent, extending recent declines.
Worries about
third-quarter earnings reports continued to weigh on sentiment.
Earnings forS&P 500 companies
are expected to have dropped nearly 5 percent year over year, which would be
the worst quarter for earnings in six years, according to Thomson Reuters data.
"There's a little nervousness about earnings reports that
we'll be seeing over the next couple or three weeks," said John Carey,
portfolio manager at Pioneer Investment Management in Boston.
"The
international situation continues to weigh on people's minds, and
commodities were weaker earlier. In the absence of any strong new economic data
or blow-away-type earnings results, people are still cautious, waiting for the
Fed to decide on whether it's going to raise rates or not," he said.
After the bell on Tuesday, shares of Intel (INTC.O) were
nearly flat in choppy trade following results, while shares of JPMorgan Chase (JPM.N),
which also reported results, were down 1.7 percent.
Earlier in the day, data showed Chinese imports fell 20 percent in September due
to weak domestic demand, indicating growth in the world's second-largest economy was sputtering.
The Dow Jones industrial
average .DJI fell 49.97 points, or 0.29 percent, to
17,081.89, theS&P 500 .SPX lost 13.77 points, or 0.68 percent, to
2,003.69 and the Nasdaq Composite.IXIC dropped 42.03 points, or 0.87 percent,
to 4,796.61.
A devaluation of China's yuan currency in late August triggered
a steep selloff in global equities. A bounce in commodities has helped stocks
recover in recent sessions, as well as investors' bets that the Federal Reserve
will keep benchmark U.S. interest rates near zero until next year.
Among results on tap this
week are reports from more big banks and other earnings bellwethers, including
Goldman Sachs (GS.N), Bank of America (BAC.N), and General Electric (GE.N).
Shares of Ryder System (R.N) were
down 9.3 percent at $68.63 - the biggest percentage decliner on the S&P 500 - while FMC Corp (FMC.N) was
down 3.1 percent at $36.35, both following disappointing forecasts late Monday.
Ryder's stock hit its lowest close in nearly two years.
Molson Coors (TAP.N) rose
9.9 percent to $86.58 after SABMiller (SAB.L)
agreed to be bought by AB Inbev (ABI.BR) for
about $106 billion. The deal is likely to result in the disposal of SAB's 58
percent stake in its U.S. joint venture with Molson Coors.
Declining issues outnumbered advancing ones on the NYSE by 2,222
to 835, while on theNasdaq, 2,039
issues fell and 763 advanced. The S&P
500 posted 12 new 52-week highs
and four new lows; the Nasdaq recorded 61 new highs and 47 new lows.
About 6.1
billion shares changed hands on U.S. exchanges, below the 7.5 billion
daily average for the past 20 trading days, according to Thomson Reuters data.
No comments:
Post a Comment